Vitreous Hemorrhage
Simple model predicts treatment success with Vitrase, says ISTA
Published in Obesity and Diabetes Week, May 29th, 2006
Incorporating data from a pooled, subset analysis of the company's two randomized, double-masked, placebo-controlled phase III clinical studies of Vitrase for the treatment of vitreous hemorrhage, the posters, entitled "A Simple Predictor of Vitrase Efficacy for BCVA Improvement in Diabetic Patients With Severe Vitreous Hemorrhage" and "A Simple Predictor of Vitrase Efficacy for Successful Laser Treatment in Diabetic Patients With...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Complications
Obesity common among type 2 diabetes in secondary care - Diabetes Pathogenesis
alpha2 -Heremans-Schmid glycoprotein is linked to insulin resistance and fat accumulation - Diet & Nutrition
Cereal fiber improves whole-body insulin sensitivity in overweight and obese women - Gastric Bypass
Roux-en-Y gastric bypass effectively treated comorbid conditions in super-obese - Obesity & Coronary Artery Disease
Obese coronary artery disease patients undergoing MPS were at lower risk of cardiac death - Adipose Tissue
Immunoglobulins produced by adipose tissue cells may alter metabolism and cytokine production - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
